TRANSGENE SA   EO 0,50
TRANSGENE SA EO 0,50
Aktie · FR0005175080 · 913048 (XPAR)
Übersicht Finanzkennzahlen
0,95 EUR
-4,44 % -0,04 EUR
Paris (XLON) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 14:09

Aktuelle Kurse von TRANSGENE SA EO 0,50

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XLON: London
London
0OCQ.L
EUR
06.06.2025 14:09
0,95 EUR
0,99 EUR
-4,44 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 37,79 % 54,40 % 34,47 % 23,12 % -6,88 % -6,88 %

Firmenprofil zu TRANSGENE SA EO 0,50 Aktie

Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clinical trial for the treatment of ovarian cancer, and human papilloma virus (HPV)-negative head and neck cancers; TG4001, a therapeutic vaccine, which is in phase II clinical trial for the treatment of HPV-positive cancers; TG6002, an oncolytic virus that is in phase I/IIa clinical trial for the treatment of various solid tumors, such as gastrointestinal adenocarcinoma comprising stomach, pancreas, and colon; and BT-001, an oncolytic virus, which is in phase I/II clinical trial for the treatment of solid tumors. The company also develops TG1050, a therapeutic vaccine for the treatment of chronic hepatitis B; and Pexa-Vec, an oncolytic virus for the treatment of solid tumors. It has strategic collaboration agreements with AstraZeneca, Merck KGaA, Pfizer, PersonGen BioTherapeutics, and NEC Corporation; licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva; and agreements with Sanofi, BioInvent, and Randox. The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS.

Unternehmensdaten

Name TRANSGENE SA EO 0,50
Firma Transgene SA
Website https://www.transgene.fr
Heimatbörse XPAR Paris
WKN 913048
ISIN FR0005175080
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Pharmaceuticals
CEO Dr. Alessandro Riva M.D.
Marktkapitalisierung 38 Mio
Land Frankreich
Währung EUR
Mitarbeiter 0,1 T
Adresse 400, Boulevard Gonthier d’Andernach, 67405 Illkirch-Graffenstaden
IPO Datum 2008-11-05

Ticker Symbole

Name Symbol
Frankfurt TGNA.F
London 0OCQ.L

Weitere Aktien

Investoren die TRANSGENE SA EO 0,50 die halten, haben auch folgende Aktien im Depot:
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
DZ BANK IS.A1154
DZ BANK IS.A1154 Anleihe
HANSAINTERNATIONAL CL. A
HANSAINTERNATIONAL CL. A Fonds
INTEL CORP
INTEL CORP Aktie
KLA CORP
KLA CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
NUCO CORP
NUCO CORP Aktie
NVIDIA CORP
NVIDIA CORP Aktie
STARBUCKS CORP
STARBUCKS CORP Aktie
TEUCRIUM CFUND ETV
TEUCRIUM CFUND ETV Fonds
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025